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ABSTRACT 23 
Molecular diagnosis using real-time polymerase chain reaction (PCR) may allow earlier 24 
diagnosis of rickettsiosis. We developed a real-time duplex PCR that amplifies (i) DNA of any 25 
rickettsial species and (ii) DNA of both typhus group rickettsia, i.e. R. prowazekii and R. 26 
typhi. Primers and probes were selected to amplify a segment of the 16S rRNA gene of 27 
Rickettsia spp. for the pan-rickettsial PCR and the citrate synthase gene (gltA) for the typhus 28 
group rickettsia PCR. Analytical sensitivity was 10 copies of control plasmid DNA per 29 
reaction. No cross-amplification was observed when testing human DNA and 22 pathogens 30 
or skin commensals. Real-time PCR was applied to 16 clinical samples. Rickettsial DNA was 31 
detected in the skin biopsies of 3 patients. In one patient with severe murine typhus, the 32 
typhus group PCR was positive in a skin biopsy from a petechial lesion and seroconversion 33 
was later documented. The two other patients with negative typhus group PCR suffered from 34 
Mediterranean and African spotted fever, respectively; in both cases, skin biopsy was 35 
performed on the eschar. Our real-time duplex PCR showed a good analytical sensitivity and 36 
specificity, allowing early diagnosis of rickettsiosis among 3 patients, and recognition of 37 
typhus in one of them. 38 
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INTRODUCTION 39 
Rickettsial diseases are worldwide emerging arthropod-borne zoonoses that are caused by 40 
small obligate intracellular gram-negative rods. They are traditionally divided into the spotted 41 
fever group, the typhus group and the scrub typhus group (Parola, et al., 2005). 42 
Microbiological diagnosis of rickettsiosis is usually established by serology, as isolation in cell 43 
culture or animals is difficult and dangerous for the laboratory personnel, and 44 
immunohistochemistry is not widely available. However, since IgM increase takes 15 to 26 45 
days, serological diagnosis is usually retrospective, thus limiting the clinical impact of 46 
diagnosis (Fournier, et al., 2002). Moreover species identification is limited by cross-47 
reactions. 48 
Molecular diagnosis using polymerase chain reaction (PCR) allows earlier diagnosis of 49 
rickettsiosis and species identification. Thus, several PCR assays targeting various rickettsial 50 
genes have been developed in order to accelerate the diagnosis of rickettsiosis. While some 51 
targeted several species (Leitner, et al., 2002, Fournier & Raoult, 2004), other were designed 52 
to detect only a single rickettsial species (Choi, et al., 2005, Karpathy, et al., 2009).  Since 53 
several rickettsiae can be responsible of the same clinical syndrome, a broader spectrum is 54 
warranted. In addition, the biodiversity of rickettsial species is likely underestimated and 55 
some yet unknown species might also be pathogenic (Parola, et al., 2005). Moreover, the 56 
recognition of typhus group rickettsiosis is clinically and epidemiologically relevant, since 57 
these infections may be associated with a worse prognosis than spotted fevers (Dumler, et 58 
al., 1991, Bechah, et al., 2008). We therefore developed a real-time duplex PCR that 59 
amplifies DNA of any rickettsial species and both typhus group rickettsia, i.e. R. prowazekii 60 
and R. typhi. 61 
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METHODS 62 
Development of the real-time PCR 63 
Primers and probes were designed using Primer3 software (Rozen & Skaletsky, 2000) 64 
starting from alignments of the 16S rRNA and of the citrate synthase (gltA) genes  obtained 65 
for the different rickettsial species available in the GenBank database 66 
(http://www.ncbi.nlm.nih.gov/genbank/). 67 
For the Rickettsia spp. PCR,  a forward primer Rsp-F1 (5’-CGCAACCCTCATTCTTATTTGC-68 
3’), a second forward primer Rsp-F2 (5’-CGCAACCCTTATTCTTATTTGC-3’), a reverse 69 
primer Rsp-R (5’-TGCTACAATGGTGTTTACAGAGG-3’) and a MGB probe (minor-groove 70 
binder) labeled with 5’FAM (6-carboxyfluorescein) Rsp-Probe (5’-FAM-71 
TAAGAAAACTGCCGGTGATAAGCCGGAG-BHQ-3’) were designed  to amplify a 149–bp 72 
fragment of the 16S rRNA gene of all Rickettsia spp. This fragment was chosen because 73 
several rickettsial species including R. conorii, R. africae, R. rickettsii, R. slovaca and R. 74 
akari show an identical sequence in the selected 16S rRNA fragment (Fournier, et al., 2003). 75 
Since typhus group rickettsia differs from other rickettsial species at position 1097, the 76 
second forward primer was added. 77 
For the typhus group rickettsia PCR, the citrate synthase gene gltA was targeted, since it is 78 
less conserved among rickettsial species. To amplify R. prowazekii DNA, the forward primer 79 
Rtp-F (5’-TTCGGATTGCTGGCTCATCA-3’) and the reverse primer Rtp-R (5’-80 
GCTAAAGCTAAAGATAAGAATGATCCATTT-3’) were designed. To amplify R. typhi DNA 81 
the primers Rtt-F  (5’-TACGAATTGCTGGCTCATCA-3’) and Rtt-R (5’-82 
GCTAAAGCTAAAGACAAAAATGATCCATTT-3’) were added. Only one MGB probe was 83 
designed labelled with 5’TET (tetrachlorofluorescein phosphoramidite), Rt-Probe (5’-TET - 84 
ATCCTTTTGCATGTATTAGCACTGGTATTGCATCA--BHQ-3’), to detect both species. All 85 
primers and probes were prepared by Eurogentec (Belgium) 86 
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PCR amplification and products detection were performed with ABI Prism 7900 Sequence 87 
Detection system (Applied Biosystems, Rotkreuz, Switzerland) during 45 cycles. The 88 
reactions were performed with 0.2 µM of each primer, 0.1 µM of probe and 10µl 2x TaqMan 89 
universal master Mix (Applied Biosystem) and 5 µl DNA sample (final volume 20 µl). Cycling 90 
conditions were 2 min at 50°C, 10 min at 95°C, followed by 45 cycles during 15s at 95°C and 91 
2 min at 60°C. 92 
To obtain positive controls for both PCR and to allow quantification, 4 plasmids were 93 
constructed using rickettsial DNA from 3 species: DNA from a skin biopsy positive for R. 94 
conorii subsp. israelensis (Boillat, et al., 2008) and R. prowazekii DNA and R. typhi DNA 95 
extracted from two strains grown in cell culture (kindly provided by Prof. Didier Raoult, 96 
Université de la Méditerranée, Marseille, France). Thus, for each PCR, we obtained two 97 
positive control plasmids: (i) R. conorii and R. typhi for the pan-rickettsial real-time PCR; (ii) 98 
R. typhi and R. prowazekii controls for the typhus group real-time PCR. The genomic DNA 99 
was amplified using the polymerase AmpliTaq Gold (Applied Biosystems, Zug, Switzerland). 100 
PCR products were cloned using the TOPO TA Cloning® kit (Invitrogen, Basel, Switzerland). 101 
After isolation of plasmidic DNA using the QIAprep Spin Miniprep Kit (Qiagen, 102 
Kombrechtikon, Switzerland), quantification was performed on a Nanodrop ND-1000 (Witech, 103 
Littau, Switzerland). 104 
Analytical sensitivity, reproducibility and specificity 105 
To assess analytical sensitivity of both real-time PCR, 10-fold dilutions of the 4 positive 106 
control plasmids were tested in 5 independent runs and in 5 replicates. Intra- and inter-run 107 
reproducibility was assessed by comparing mean threshold cycle (Ct) and standard error of 108 
the mean of replicates obtained in the 5 runs. Analytical specificity of the pan-rickettsial PCR 109 
was tested using DNA extracted from 22 pathogens and skin commensals, including 110 
bacteria, fungi and virus (Table 1). In addition, the broad-range of the pan-rickettsial PCR 111 
was investigated using the following rickettsial DNA (grown in cell culture and provided by 112 
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Prof. Didier Raoult, Université de la Méditerranée, Marseille, France):  R. africae, R. conorii, 113 
R. felis, R. rickettsii, R. slovaca, R. prowazekii and R. typhi. 114 
Conversely, the specificity of the typhus group PCR was confirmed using the DNA from the 115 
spotted-group rickettsiae. 116 
Clinical samples 117 
The new rickettsia duplex real-time PCR, i.e. the pan-rickettsial PCR and the typhus group 118 
rickettsia PCR was applied to various samples taken from patients with clinical suspicion of 119 
rickettsiosis.  With one exception, tissue samples were not fixed. DNA was extracted from 120 
fresh clinical samples using MagNA Pure LC automated system (Roche) with the MagNA 121 
Pure LC DNA isolation kit I (Roche). DNA was extracted from 200µl of sample and eluted in 122 
a final volume of 100 µl. 123 
124 
RESULTS 125 
Analytical sensitivity, reproducibility and specificity 126 
Sensitivity and reproducibility of the pan-rickettsial real-time PCR are shown in figure 1. 127 
Fourteen of 25 replicates (56%) were positive with a R. conorii plasmid positive control 128 
concentration of 1 copy/reaction, and all replicates were positive at a concentration of 10 129 
copies. Similar results were obtained with the R. typhi positive control (data not shown). 130 
Intra- and inter-run reproducibility was high for both R. conorii and R. typhi positive controls 131 
(figure 1B and 2B). The average difference between ten-fold dilutions was 3.24 and 3.17 132 
cycles when testing the R. conorii and R. typhi plasmid, respectively. No cross-amplification 133 
was observed with the different microorganisms tested (Table 1). Moreover, with this PCR, 134 
we obtained an excellent positive amplification with all the different rickettsial species 135 
investigated: R. africae, R. conorii, R. felis, R. rickettsii, R. slovaca , R. prowazekii  and R. 136 
typhi  (with Ct values ranging from 18.8 to 24.8). Sensitivity of typhus group PCR was 100% 137 
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7 
at a positive control concentration of 10 copies/reaction for both plasmids (figure 2A). 138 
Specificity was high, as there was no amplification when testing DNA of R. africae, R. conorii, 139 
R. felis, R. rickettsii, and R. slovaca. 140 
Clinical application 141 
The duplex real-time PCR was applied to 16 specimens taken from 13 patients: 8 skin 142 
biopsies, 4 EDTA blood samples, 3 cerebrospinal fluids (CSF), and one pericardial fluid. 143 
Rickettsial DNA was detected in three samples from three different patients, whose clinical 144 
characteristics are summarized in Table 2. In one patient, typhus group rickettsia real-time 145 
PCR was also positive. This 43-year old man presented with fever, petechiae, pulmonary 146 
infiltrates, acute renal failure, encephalopathy and hyperbilirubinemia after a stay in Tunisia, 147 
where he was in contact with animals in his family farm. At admission both leptospirosis and 148 
rickettsiosis were suspected and he was promptly treated with ceftriaxone and doxycycline. 149 
Our duplex real-time PCR performed on a biopsy of a petechial cutaneous lesion (taken 2 150 
days after treatment start) allowed diagnosis of typhus. By contrast, EDTA blood tested 151 
negative for rickettsial DNA. During the course of illness, renal-replacement therapy was 152 
necessary and he developed heart failure with an ejection fraction of 25%. After 14 days of 153 
treatment, he recovered without sequelae. Seroconversion against Rickettsia spp. was 154 
documented 17 and 37 days after onset of symptoms for IgM (titer 1/1024) and IgG (titer 155 
1/128), respectively, but due to cross-reaction, identification at species level was not 156 
possible. A presumptive diagnosis of murine typhus was considered based on the clinical 157 
presentation, the zoonotic exposure and the PCR results. 158 
The two other patients with a positive pan-rickettsial PCR and negative typhus group PCR 159 
were clinically and epidemiologically diagnosed with Mediterranean spotted fever and African 160 
tick bite fever, after a travel to Sardinia (Southern Italy) and South Africa, respectively. Both 161 
presented with fever, headache and an inoculation eschar, while only the patient with 162 
Mediterranean spotted fever exhibited a rash and a severe disease requiring hospitalisation. 163 
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8 
Diagnosis was established in both patients by a PCR done on the biopsy of the inoculation 164 
eschar. 165 
Ten patients with negative duplex real-time PCR results presented with various clinical 166 
syndromes: encephalitis (2), fever and rash (1), fever in a returning traveller (1), fever of 167 
unknown origin in a HIV-positive patient (1), hemophagocytosis syndrome (1), acute liver 168 
failure and pericardial tamponade (1), skin nodules (1), bilateral lung infiltrates (1). In one 169 
case, no clinical information was available. Five patients had a history of travel to an endemic 170 
region. Serology for Rickettsia spp. was performed in 6 cases and was negative or showed a 171 
pattern of past infection. 172 
DISCUSSION 173 
A duplex real-time PCR targeting all rickettsial species and the typhus group rickettsiae was 174 
developed to detect rickettsial DNA in clinical samples and to identify agents of typhus. The 175 
test was sensitive for at least 10 DNA copies per reaction and exhibited a good 176 
reproducibility. Its application to clinical samples (skin biopsies) from patients with clinical 177 
suspicion of rickettsiosis allowed diagnosis of spotted fever in two cases, and recognition of 178 
murine typhus in another case. 179 
Timely diagnosis of rickettsiosis can be challenging, since seroconversion occurs usually in 180 
the convalescent phase (Brouqui, et al., 2004). For example, by using indirect fluorescent 181 
antibody assay, diagnostic titers of R. typhi antibodies are found 15 days after onset of 182 
symptoms (Dumler, et al., 1991). For R. conori and R. africae median time to IgM 183 
seroconversion is even longer (16 and 25 days, respectively) (Fournier, et al., 2002). 184 
Therefore, since the first report of use of molecular methods for the detection of rickettsiosis 185 
(Tzianabos, et al., 1989), several assays have been developed. Primers have usually 186 
targeted outer membrane protein genes ompA (Fournier & Raoult, 2004) and ompB (Paris, et 187 
al., 2008), the citrate synthase gene gltA (Roux, et al., 1997) and the 17-kD protein gene 188 
(Leitner, et al., 2002). In this work, we selected the 16S rRNA gene for the Rickettsia spp 189 
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9 
PCR and were able to target a gene region that was conserved among all rickettsial species. 190 
The gltA gene was chosen for the typhus group rickettsia, due to its higher variability. 191 
Due to its broad spectrum and the low discriminative power of the 16S rRNA gene, our pan-192 
rickettsial PCR is not able to precisely identify the rickettsia at species level. Species 193 
identification is warranted, since several species can be responsible of the same clinical 194 
picture. Practically, we recommend DNA amplification and sequencing of gltA and ompA 195 
genes (Fournier & Raoult, 2004), which allow identification at species and subspecies level 196 
(Boillat, et al., 2008). 197 
Despite the limited number of samples tested and their heterogeneity, the clinical experience 198 
with the new duplex real-time PCR is encouraging. Since its development in 2007, we could 199 
confirm the clinical suspicion of rickettsial infection in 3 cases. Moreover, the test allowed 200 
rapid identification of typhus in a patient with a severe febrile illness after a stay in Tunisia. 201 
Clinical presentation was non-specific, and in particular leptospirosis was suspected initially 202 
because of the triad of rash, hyperbilirubinemia and acute renal failure. This case illustrates 203 
that clinical recognition of rickettsiosis may be difficult and that empirical treatment with 204 
doxycycline is indicated in case of severe illnesses in returning travelers. 205 
It should be noted that only skin biopsies were positive in this series. PCR has been 206 
successfully applied to blood and serum samples (Leitner, et al., 2002, Choi, et al., 2005) , 207 
arthropod vectors (Karpathy, et al., 2009), but most studies have used skin biopsies 208 
(Fournier & Raoult, 2004). Biopsies of the inoculation eschar, when present, have the best 209 
diagnostic efficiency (Fournier & Raoult, 2004). In case of rickettsioses that are not 210 
associated with an eschar (e.g. murine typhus), skin biopsy should be performed on  skin 211 
lesions (maculopapular or petechial lesions), since endothelial cells are the site of 212 
multiplication of rickettsiae (Walker, et al., 2003) and since these skin lesions generally result 213 
from local rickettsial multiplication. As highlighted in this case, PCR of a skin lesion may 214 
remain positive even after a few days of doxycycline treatment. 215 
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In conclusion, we have developed a duplex real-time PCR for the direct detection of 216 
rickettsial DNA and for the identification of typhus group rickettsia. Optimal use of the assay 217 
includes its application to skin biopsy of patients presenting a clinical picture and 218 
epidemiological features compatible with a rickettsial infection. Furthermore, the broad range 219 
format of the pan-rickettsial PCR may allow the identification of new rickettsial species. 220 
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Table 1. 
List of DNA of strains tested to investigate the specificity of the rickettsial PCR. 
Species Source/strain 
Aspergillus fumigatus Clinical specimen 
Aspergillus terreus Clinical specimen 
Candida albicans ATCC 90028 
Candida glabrata Clinical specimen 
Chlamydia pneumoniae Clinical specimen 
Chlamydia trachomatis Clinical specimen 
Corynebacterium pyogenes Clinical specimen 
Escherichia coli ATCC 25922 
Herpes simplex virus 1 Clinical specimen 
Herpes simplex virus 2 Clinical specimen 
Kingella kingae Clinical specimen 
Lactobacillus spp. Clinical specimen 
Mycoplasma pneumoniae Clinical specimen 
Neisseria lactamica Clinical specimen 
Neisseria subflava Clinical specimen 
Neisseria weaveri Clinical specimen 
Pseudomonas aeruginosa ATCC 27853 
Staphylococcus aureus ATCC 43300 
Staphylococcus epidermidis Clinical specimen 
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14 
Streptococcus mitis Clinical specimen 
Streptococcus pyogenes Clinical specimen 
Varicella zoster virus Clinical specimen 
Human DNA Human Genomic DNA (Roche Diagnostics, Basel, 
Switzerland) 
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Table 2. 
Clinical characteristics and results of laboratory investigations of the three patients with positive PCR. 
Patient 
no 
Age Sex Clinical 
presentation 
Laboratory 
findings 
Complications Travel 
history 
Sample Rickettsia 
spp 
PCR, DNA 
copies/ml 
(mean Ct 
value) 
Typhus 
group 
PCR DNA 
copies/ml 
(mean Ct 
value) 
Serology Final 
diagnosis 
1 35 F Fever 
Headache 
Rash 
Eschar 
Leucopenia 
Thrombocytopenia 
ELT 
None Italy Skin 
biopsy 
7886 (31.4) Negative NA MSF 
2 41 F Fever 
Headache 
Eschar 
NA None South 
Africa 
Skin 
biopsy 
 791 (35.9) Negative Negative ATBF 
3 43 M Fever 
Headache 
Myalgia 
Dysphagia 
Cough 
Rash 
Thrombocytopenia 
Elevated 
creatinine 
ELT 
Hyperbilirubinemia 
Acute renal 
failure 
Encephalopathy 
Myocarditis 
Tunisia Skin 
biopsy 
137 (39.5) 171 (40.1) Seroconversion after 
17 days 
Murine 
typhus 
ELT: elevated liver enzymes. NA: not available. MSF: Mediterranean Spotted Fever. ATBF: African Tick-Bite Fever 
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Sensitivity and reproducibility of the pan-rickettsial real-time PCR (R. conorii positive control plasmid).  A. 
Analytical sensitivity. B. Inter-run and intra-run reproductibility assessed using 101 to 104 positive control 
plasmid copies/reaction (copies/5microl) in 5 independent runs. Error bars represent the standard error of 
the mean of replicates.  
124x166mm (300 x 300 DPI)  
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Sensitivity and reproducibility of the typhus group rickettsia real-time PCR (R. typhi positive control 
plasmid).  A. Analytical sensitivity. B. Inter-run and intra-run reproductibility assessed using 101 to 104 
positive control plasmid copies/5microl in 5 independent runs. Error bars represent the standard error of the 
mean of replicates.  
122x164mm (300 x 300 DPI)  
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